212 related articles for article (PubMed ID: 7790775)
1. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
Alleva DG; Walker TM; Elgert KD
J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
3. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
Alleva DG; Burger CJ; Elgert KD
J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
[TBL] [Abstract][Full Text] [Related]
4. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
Alleva DG; Askew D; Burger CJ; Elgert KD
J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
6. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
Alleva DG; Burger CJ; Elgert KD
Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
[TBL] [Abstract][Full Text] [Related]
8. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
Alleva DG; Elgert KD
Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
[TBL] [Abstract][Full Text] [Related]
9. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
Alleva DG; Burger CJ; Elgert KD
Immunobiology; 1993 Aug; 188(4-5):430-45. PubMed ID: 8244447
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
Denbow CJ; Conroy JM; Elgert KD
Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
[TBL] [Abstract][Full Text] [Related]
12. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
Yurochko AD; Burger CJ; Elgert KD
Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced variations in a high molecular weight inhibitory monokine.
Malick AP; Yurochko AD; Burger CJ; Askew D; Elgert KD
Immunobiology; 1989 Feb; 178(4-5):361-79. PubMed ID: 2785483
[TBL] [Abstract][Full Text] [Related]
14. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.
Mullins DW; Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1997 Aug; 37(1):63-73. PubMed ID: 9285245
[TBL] [Abstract][Full Text] [Related]
15. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunol Invest; 1993 Apr; 22(3):169-87. PubMed ID: 8099569
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
Askew D; Burger CJ; Elgert KD
Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Immunol Invest; 1993; 22(6-7):463-76. PubMed ID: 8262568
[TBL] [Abstract][Full Text] [Related]
18. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
[TBL] [Abstract][Full Text] [Related]
19. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
Mullins DW; Walker TM; Burger CJ; Elgert KD
Cancer Immunol Immunother; 1997 Oct; 45(1):20-8. PubMed ID: 9353423
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production.
Langermans JA; Nibbering PH; Van Vuren-Van Der Hulst ME; Van Furth R
Parasite Immunol; 2001 Apr; 23(4):169-75. PubMed ID: 11298293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
